A Follow-up Extension Study to Evaluate the Persistence of Immune Response

See also
Status	Clinical Trial	Phase
Active, not recruiting	`NCT04537156` - Efficacy, Immunogenicity and Safty Study of Recombinant Human Papillomavirus Vaccine(6,11,16,18,31,33,45,52,58 Type)(E.Coli)	Phase 3
Completed	`NCT02907333` - Testing Use of Condoms on Regression of Cervical Intraepithelial Neoplasia	N/A
Recruiting	`NCT02576262` - HPV Integration Testing for Human Papillomavirus-Positive Women	N/A
Completed	`NCT01029990` - Randomized Controlled Trial to Study Interventions to Increase Participation in Cervical Cancer Screening Program	Phase 0
Recruiting	`NCT05078528` - Low-cost Imaging Technology for Global Prevention of Cervical Cancer	N/A
Recruiting	`NCT05502367` - A Study of ABI-2280 Vaginal Tablet in Participants With Cervical Intraepithelial Neoplasia	Phase 1/Phase 2
Completed	`NCT02494310` - HRME: Screening for Cervical Cancer and Its Precursors in Low‐Resource Settings	N/A
Active, not recruiting	`NCT03429582` - Comparison of Cervical CIN II/III Treatment Outcomes With Thermal Ablation Device	N/A
Active, not recruiting	`NCT02140021` - Biospecimen Collection and Testing for the Prevalence of Anal Dysplasia and Anal Cancer in Patients With Cervical, Vaginal and Vulvar Dysplasia and Cancer	N/A
Not yet recruiting	`NCT05510830` - Diagnostic Cervical Conization for Persistent Infection or Integration of HPV	N/A
Completed	`NCT02237326` - Visual Inspection With Acetic Acid Compared to Lugol's Iodine in HIV-infected Women	N/A
Completed	`NCT00316706` - Human Papilloma Virus (HPV) Vaccine Trial in Young Adolescent Women With GlaxoSmithKline Biologicals' (GSK Bio) HPV-16/18 Vaccine	Phase 3
Withdrawn	`NCT03143491` - Study of SOR007 Ointment for Cervical Intraepithelial Neoplasia (CIN)	Phase 2
Completed	`NCT03293628` - Comparing Two Techniques of Haemostasis After Cervical Conization	Phase 2
Recruiting	`NCT05266898` - Immunogenicity of Gardasil-9 HPV Vaccine in People Living With HIV	Phase 4
Completed	`NCT02481414` - A Clinical Trial of PepCan to Two Therapy Arms for Treating Cervical High-Grade Squamous Intraepithelial Lesions	Phase 2
Completed	`NCT02247999` - Improving Cervical Cancer Screening Among HIV-Infected Women in India
Recruiting	`NCT04646954` - DNA Methylation Testing for the Screening of Uterine Cervical Lesion	Phase 3
Recruiting	`NCT04650711` - Immunohistochemical Staining of p16 for the Screening of Cervical Cancer	Phase 2
Completed	`NCT01544478` - V501 Safety and Efficacy Study in Japanese Women Aged 16 to 26 Years (V501-110)	Phase 4

NCT number	NCT03355820
Study type	Interventional
Source	GlaxoSmithKline
Contact
Status	Completed
Phase	Phase 3
Start date	February 28, 2018
Completion date	June 29, 2018

A Follow-up Extension Study to Evaluate the Persistence of Immune Response to GSK Biologicals' HPV Vaccine in Healthy Chinese Female Subjects Who Received Three Doses of the Vaccine in the HPV-058 Study

Clinical Trial Summary

Clinical Trial Description

Study Design

Related Conditions & MeSH terms